MMP11 is a matrix metalloproteinase that promotes epithelial-mesenchymal transition and tumor progression [34] and ENG (endoglin or CD105) is often upregulated in different types of cancers, particularly during tumor progression, with higher levels correlating with various clinicopathologic factors worse survival and metastases [35,36,37]. The gene discussed is MMP11; the disease is cancer.